News | April 05, 2011

Study Shows Gamma Knife Radiosurgery Spares More Healthy Tissue

April 5, 2011 – The volume of normal brain tissue exposed to radiation during treatment for multiple metastases appears to depend on which stereotactic radiosurgery system is employed, according to a recent study in the Journal of Neurosurgery.

Comparing treatment plans developed for use by three different treatment systems for a single patient (already previously treated with Leksell Gamma Knife), researchers found that Gamma Knife plans would result in "much smaller normal brain volumes receiving any particular dose" than the two other systems' plans.

The study compared treatment plans by Washington Fremont Hospital's (Fremont, Calif.) Leksell Gamma Knife Perfexion, the University of Utah's (Salt Lake City) BrainLAB Novalis system and the University of California San Francisco's Accuray CyberKnife system and involved a patient with 12 metastatic brain lesions.

"The discrepancy in normal brain volumes exposed between the Gamma Knife plans and those from CyberKnife and BrainLAB was generally on the order of two to three times lower for the Gamma Knife plans," says David Larson, M.D., Ph.D., radiation oncologist and co-medical director at Washington Fremont Hospital's Gamma Knife Program. "You could expect that patients and physicians would look more favorably on any radiation therapy treatment option that can demonstrate lower unintended radiation exposure to normal tissues."

This study is particularly compelling given trends in cancer survival and incidence. A major outcome of improved cancer therapies is that patients are living longer, which in turn may result in a higher incidence of patients experiencing recurrent brain metastases. Accordingly, for this growing population of cancer survivors, effective treatment of multiple brain metastases is increasingly essential.

For more information: www.elekta.com

Related Content

Elekta Expands Mosaiq Oncology Information System With PalabraApps
News | Oncology Information Management Systems (OIMS) | April 20, 2018
April 20, 2018 — Elekta announced that it is making a strategic investment in PalabraApps LLC to advance the developm
This image, taken with Canon's Aquilion One, shows a lung with metastases from bowel cancer.

This image, taken with Canon’s Aquilion One, shows a lung with metastases from bowel cancer. Image courtesy of Canon.

Feature | Lung Cancer | April 18, 2018 | Jeff Zagoudis
In recent years, low-dose computed tomography (CT) screening has emerged as a proven, effective method to detect lung
Varian Launches Velocity 4.0 Cancer Imaging Software
Technology | Treatment Planning | April 16, 2018
April 16, 2018 — Varian announced a new version of its Velocity cancer imaging software that includes Rapidsphere, a
First Patient Treated in Online Adaptive Radiotherapy Trial With CyberKnife System
News | Stereotactic Body Radiation Therapy (SBRT) | April 06, 2018
Accuray Inc. and Erasmus MC announced the first patient has been successfully treated using an online-adaptive (OA)...
First Patient Treated on Mevion's S250i Proton Therapy System
News | Proton Therapy | April 05, 2018
Mevion Medical Systems announced the treatment of the first patient in the world on the Mevion S250i Proton Therapy...
ASTRO Updates Guidelines for Palliative Lung Radiation Therapy
News | Radiation Therapy | April 05, 2018
The American Society for Radiation Oncology (ASTRO) issued an update to its clinical guideline for the use of...
Combination Radiotherapy Beneficial in Treating Prostate Cancer
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with...
Loyola Study Finds Medical Students Receive Little Formal Instruction in Radiation Oncology
News | Radiation Therapy | March 26, 2018
Medical school students receive little formal instruction in radiation oncology, a Loyola study has found.
Overlay Init